| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Hexosyltransferases | 28 | 2019 | 40 | 7.110 |
Why?
|
| Membrane Proteins | 37 | 2019 | 895 | 6.400 |
Why?
|
| Endoplasmic Reticulum | 18 | 2019 | 173 | 3.030 |
Why?
|
| Protein Processing, Post-Translational | 12 | 2019 | 263 | 2.370 |
Why?
|
| Saccharomyces cerevisiae Proteins | 14 | 2021 | 445 | 2.140 |
Why?
|
| SEC Translocation Channels | 11 | 2021 | 38 | 2.120 |
Why?
|
| Glycoproteins | 8 | 2019 | 186 | 2.000 |
Why?
|
| Glycosylation | 25 | 2019 | 137 | 1.860 |
Why?
|
| Saccharomyces cerevisiae | 10 | 2021 | 565 | 1.680 |
Why?
|
| Asparagine | 5 | 2019 | 25 | 1.310 |
Why?
|
| Protein Transport | 14 | 2021 | 402 | 1.250 |
Why?
|
| Protein Sorting Signals | 5 | 2013 | 55 | 1.180 |
Why?
|
| Cation Transport Proteins | 3 | 2019 | 20 | 1.070 |
Why?
|
| Protein Biosynthesis | 8 | 2016 | 320 | 0.990 |
Why?
|
| Oligosaccharides | 4 | 2018 | 54 | 0.930 |
Why?
|
| Campylobacter lari | 2 | 2017 | 2 | 0.920 |
Why?
|
| Eukaryotic Cells | 4 | 2019 | 57 | 0.910 |
Why?
|
| Proteins | 5 | 2015 | 750 | 0.890 |
Why?
|
| Ribosomes | 8 | 2018 | 163 | 0.800 |
Why?
|
| Membrane Transport Proteins | 7 | 2013 | 135 | 0.790 |
Why?
|
| Endoplasmic Reticulum, Rough | 2 | 2013 | 5 | 0.780 |
Why?
|
| Models, Molecular | 10 | 2019 | 1150 | 0.700 |
Why?
|
| Signal Recognition Particle | 3 | 2008 | 39 | 0.690 |
Why?
|
| HeLa Cells | 8 | 2019 | 536 | 0.640 |
Why?
|
| Prokaryotic Cells | 1 | 2019 | 7 | 0.610 |
Why?
|
| Tumor Suppressor Proteins | 3 | 2019 | 198 | 0.580 |
Why?
|
| Lipopolysaccharides | 3 | 2018 | 624 | 0.580 |
Why?
|
| Proteomics | 2 | 2019 | 283 | 0.570 |
Why?
|
| Oxidoreductases | 2 | 2017 | 64 | 0.570 |
Why?
|
| Protein Structure, Tertiary | 7 | 2013 | 673 | 0.550 |
Why?
|
| Receptors, Peptide | 3 | 2008 | 34 | 0.550 |
Why?
|
| Substrate Specificity | 7 | 2017 | 339 | 0.550 |
Why?
|
| Hemopexin | 2 | 2014 | 5 | 0.530 |
Why?
|
| Amino Acid Motifs | 5 | 2018 | 153 | 0.530 |
Why?
|
| HEK293 Cells | 9 | 2019 | 621 | 0.520 |
Why?
|
| Congenital Disorders of Glycosylation | 4 | 2019 | 7 | 0.520 |
Why?
|
| Intracellular Membranes | 2 | 2007 | 50 | 0.520 |
Why?
|
| Receptors, Cytoplasmic and Nuclear | 3 | 2008 | 147 | 0.510 |
Why?
|
| Protein Structure, Secondary | 4 | 2012 | 260 | 0.500 |
Why?
|
| Protein Binding | 8 | 2018 | 1602 | 0.480 |
Why?
|
| Bacterial Proteins | 2 | 2017 | 768 | 0.430 |
Why?
|
| Haptoglobins | 1 | 2013 | 13 | 0.420 |
Why?
|
| Benzamides | 3 | 2019 | 65 | 0.410 |
Why?
|
| Homeostasis | 1 | 2016 | 368 | 0.410 |
Why?
|
| Sulfonamides | 3 | 2019 | 127 | 0.390 |
Why?
|
| Fungal Proteins | 3 | 2017 | 147 | 0.380 |
Why?
|
| Polysaccharides | 7 | 2019 | 144 | 0.380 |
Why?
|
| Crystallography, X-Ray | 4 | 2019 | 433 | 0.380 |
Why?
|
| RNA, Fungal | 1 | 2012 | 43 | 0.370 |
Why?
|
| Biocatalysis | 1 | 2011 | 48 | 0.350 |
Why?
|
| Protein Conformation | 5 | 2019 | 780 | 0.350 |
Why?
|
| Fluid Therapy | 2 | 2020 | 47 | 0.330 |
Why?
|
| Vasoconstrictor Agents | 2 | 2020 | 70 | 0.320 |
Why?
|
| Humans | 34 | 2021 | 63586 | 0.320 |
Why?
|
| Evolution, Molecular | 4 | 2007 | 322 | 0.310 |
Why?
|
| Protein Folding | 6 | 2018 | 267 | 0.310 |
Why?
|
| Protein Subunits | 3 | 2008 | 166 | 0.310 |
Why?
|
| Protozoan Proteins | 2 | 2007 | 126 | 0.310 |
Why?
|
| Animals | 22 | 2019 | 20675 | 0.300 |
Why?
|
| Receptor Protein-Tyrosine Kinases | 2 | 2019 | 52 | 0.280 |
Why?
|
| HSP70 Heat-Shock Proteins | 2 | 2019 | 78 | 0.270 |
Why?
|
| Cell Line | 6 | 2018 | 2040 | 0.270 |
Why?
|
| Protein Interaction Domains and Motifs | 2 | 2017 | 86 | 0.270 |
Why?
|
| Arsenite Transporting ATPases | 1 | 2007 | 2 | 0.270 |
Why?
|
| Cell Membrane | 3 | 2019 | 496 | 0.270 |
Why?
|
| Molecular Sequence Data | 6 | 2013 | 1991 | 0.260 |
Why?
|
| Kinetics | 3 | 2017 | 763 | 0.260 |
Why?
|
| Transferases | 2 | 2003 | 17 | 0.260 |
Why?
|
| Amino Acid Sequence | 5 | 2018 | 1592 | 0.260 |
Why?
|
| GTP Phosphohydrolases | 2 | 2004 | 60 | 0.250 |
Why?
|
| Escherichia coli Proteins | 1 | 2009 | 271 | 0.250 |
Why?
|
| Catalytic Domain | 3 | 2018 | 199 | 0.250 |
Why?
|
| Mutation, Missense | 3 | 2019 | 185 | 0.250 |
Why?
|
| Protein Modification, Translational | 1 | 2005 | 6 | 0.240 |
Why?
|
| Hospital Mortality | 2 | 2020 | 879 | 0.240 |
Why?
|
| Enzyme Inhibitors | 2 | 2018 | 373 | 0.240 |
Why?
|
| Mutation | 5 | 2017 | 2611 | 0.230 |
Why?
|
| Transfection | 2 | 2017 | 694 | 0.220 |
Why?
|
| Gene Expression | 3 | 2017 | 840 | 0.210 |
Why?
|
| Protein Domains | 2 | 2021 | 149 | 0.200 |
Why?
|
| CRISPR-Cas Systems | 2 | 2017 | 361 | 0.190 |
Why?
|
| Peptides | 4 | 2017 | 574 | 0.190 |
Why?
|
| RNA Interference | 2 | 2017 | 618 | 0.190 |
Why?
|
| Clonidine | 1 | 2021 | 25 | 0.180 |
Why?
|
| Cryoelectron Microscopy | 3 | 2019 | 200 | 0.180 |
Why?
|
| Cytosol | 3 | 2017 | 180 | 0.180 |
Why?
|
| Methanococcus | 2 | 2012 | 5 | 0.180 |
Why?
|
| Protein Isoforms | 2 | 2014 | 197 | 0.180 |
Why?
|
| Hydrophobic and Hydrophilic Interactions | 2 | 2012 | 265 | 0.180 |
Why?
|
| Shock | 1 | 2020 | 33 | 0.170 |
Why?
|
| Structure-Activity Relationship | 4 | 2018 | 373 | 0.160 |
Why?
|
| Shock, Septic | 1 | 2020 | 86 | 0.160 |
Why?
|
| Protein Multimerization | 2 | 2018 | 176 | 0.150 |
Why?
|
| Entamoeba histolytica | 3 | 2008 | 14 | 0.150 |
Why?
|
| Escherichia coli | 2 | 2017 | 707 | 0.150 |
Why?
|
| von Willebrand Diseases | 1 | 2019 | 4 | 0.150 |
Why?
|
| Hemophilia A | 1 | 2019 | 57 | 0.150 |
Why?
|
| Herpes Simplex | 1 | 2019 | 50 | 0.150 |
Why?
|
| Herpesvirus 1, Human | 1 | 2019 | 82 | 0.140 |
Why?
|
| Community Participation | 1 | 2018 | 46 | 0.140 |
Why?
|
| Factor VIII | 1 | 2018 | 32 | 0.140 |
Why?
|
| Protein Conformation, beta-Strand | 1 | 2017 | 10 | 0.140 |
Why?
|
| Conserved Sequence | 1 | 2018 | 173 | 0.140 |
Why?
|
| Protein Conformation, alpha-Helical | 1 | 2017 | 22 | 0.140 |
Why?
|
| Multiple Chronic Conditions | 1 | 2018 | 39 | 0.140 |
Why?
|
| RNA, Messenger | 3 | 2013 | 1536 | 0.140 |
Why?
|
| Cardiac Surgical Procedures | 1 | 2021 | 267 | 0.140 |
Why?
|
| Amino Acid Substitution | 1 | 2018 | 239 | 0.140 |
Why?
|
| Community Mental Health Services | 1 | 2018 | 94 | 0.130 |
Why?
|
| Ascomycota | 1 | 2017 | 12 | 0.130 |
Why?
|
| Cloning, Molecular | 1 | 2017 | 383 | 0.130 |
Why?
|
| Models, Biological | 2 | 2014 | 1181 | 0.130 |
Why?
|
| Dengue Virus | 1 | 2017 | 99 | 0.130 |
Why?
|
| Lectins | 2 | 2014 | 41 | 0.130 |
Why?
|
| Endoplasmic Reticulum-Associated Degradation | 1 | 2016 | 3 | 0.130 |
Why?
|
| Binding Sites | 5 | 2018 | 906 | 0.120 |
Why?
|
| Cell Line, Tumor | 3 | 2016 | 1470 | 0.120 |
Why?
|
| Medical Order Entry Systems | 1 | 2016 | 42 | 0.120 |
Why?
|
| Cellular Senescence | 1 | 2016 | 111 | 0.120 |
Why?
|
| Recombinant Proteins | 1 | 2017 | 703 | 0.120 |
Why?
|
| Plasmids | 1 | 2016 | 292 | 0.110 |
Why?
|
| Host-Pathogen Interactions | 1 | 2017 | 262 | 0.110 |
Why?
|
| Genetic Engineering | 1 | 2016 | 117 | 0.110 |
Why?
|
| Calreticulin | 1 | 2014 | 4 | 0.110 |
Why?
|
| Phenotype | 2 | 2011 | 1206 | 0.110 |
Why?
|
| Cysteine | 1 | 2014 | 108 | 0.110 |
Why?
|
| Intensive Care Units | 3 | 2021 | 407 | 0.100 |
Why?
|
| Base Sequence | 1 | 2016 | 1331 | 0.100 |
Why?
|
| Dose-Response Relationship, Drug | 3 | 2020 | 863 | 0.100 |
Why?
|
| Point Mutation | 3 | 2013 | 166 | 0.100 |
Why?
|
| Mutagenesis, Site-Directed | 2 | 2011 | 249 | 0.100 |
Why?
|
| Databases, Protein | 1 | 2013 | 47 | 0.100 |
Why?
|
| Presenilins | 1 | 2012 | 4 | 0.100 |
Why?
|
| Presenilin-2 | 1 | 2012 | 20 | 0.100 |
Why?
|
| Presenilin-1 | 1 | 2012 | 61 | 0.090 |
Why?
|
| Molecular Conformation | 2 | 2009 | 133 | 0.090 |
Why?
|
| Cells, Cultured | 4 | 2013 | 2155 | 0.090 |
Why?
|
| Models, Genetic | 1 | 2013 | 260 | 0.090 |
Why?
|
| Cathepsin A | 1 | 2011 | 4 | 0.090 |
Why?
|
| Dipeptidyl-Peptidases and Tripeptidyl-Peptidases | 1 | 2011 | 10 | 0.090 |
Why?
|
| Lysosomes | 1 | 2012 | 166 | 0.090 |
Why?
|
| Depression | 1 | 2018 | 906 | 0.090 |
Why?
|
| Potassium Channels, Voltage-Gated | 1 | 2011 | 32 | 0.090 |
Why?
|
| Mice | 5 | 2018 | 10843 | 0.090 |
Why?
|
| Quality of Life | 1 | 2018 | 1241 | 0.090 |
Why?
|
| RNA, Small Interfering | 2 | 2014 | 921 | 0.090 |
Why?
|
| APACHE | 2 | 2020 | 43 | 0.080 |
Why?
|
| Organ Dysfunction Scores | 2 | 2020 | 23 | 0.080 |
Why?
|
| Multiprotein Complexes | 1 | 2011 | 154 | 0.080 |
Why?
|
| Autophagy | 1 | 2012 | 225 | 0.080 |
Why?
|
| Thermus | 1 | 2009 | 2 | 0.080 |
Why?
|
| Lipid Bilayers | 1 | 2009 | 53 | 0.080 |
Why?
|
| Gene Knockdown Techniques | 1 | 2009 | 202 | 0.070 |
Why?
|
| Gene Knockout Techniques | 2 | 2018 | 95 | 0.070 |
Why?
|
| Protein Precursors | 2 | 2005 | 83 | 0.070 |
Why?
|
| Trichomonas vaginalis | 1 | 2007 | 9 | 0.070 |
Why?
|
| Mannose | 1 | 2007 | 22 | 0.070 |
Why?
|
| Gene Expression Regulation, Fungal | 1 | 2008 | 127 | 0.070 |
Why?
|
| beta-Fructofuranosidase | 1 | 2006 | 2 | 0.060 |
Why?
|
| Trypanosoma cruzi | 1 | 2007 | 52 | 0.060 |
Why?
|
| Dogs | 2 | 2009 | 329 | 0.060 |
Why?
|
| Permeability | 1 | 2006 | 49 | 0.060 |
Why?
|
| Translocation, Genetic | 1 | 2006 | 70 | 0.060 |
Why?
|
| Homozygote | 2 | 2019 | 124 | 0.060 |
Why?
|
| Calcium-Binding Proteins | 1 | 2006 | 92 | 0.060 |
Why?
|
| Ubiquitin | 1 | 2006 | 99 | 0.060 |
Why?
|
| Yeasts | 1 | 2005 | 49 | 0.060 |
Why?
|
| Cryptococcus neoformans | 1 | 2007 | 148 | 0.060 |
Why?
|
| Glycosyltransferases | 1 | 2005 | 9 | 0.060 |
Why?
|
| Metabolic Diseases | 1 | 2005 | 58 | 0.060 |
Why?
|
| Liposomes | 1 | 2005 | 105 | 0.050 |
Why?
|
| Sequence Alignment | 1 | 2005 | 299 | 0.050 |
Why?
|
| Biological Transport | 1 | 2005 | 291 | 0.050 |
Why?
|
| Transferases (Other Substituted Phosphate Groups) | 1 | 2003 | 2 | 0.050 |
Why?
|
| Carbohydrate Metabolism, Inborn Errors | 1 | 2003 | 2 | 0.050 |
Why?
|
| Guanosine Triphosphate | 1 | 2004 | 50 | 0.050 |
Why?
|
| Sequence Homology, Nucleic Acid | 1 | 2003 | 112 | 0.050 |
Why?
|
| Membrane Glycoproteins | 1 | 2006 | 669 | 0.050 |
Why?
|
| Adult | 4 | 2021 | 16885 | 0.050 |
Why?
|
| Prospective Studies | 2 | 2020 | 3303 | 0.050 |
Why?
|
| Gene Expression Regulation, Enzymologic | 1 | 2003 | 131 | 0.050 |
Why?
|
| Signal Transduction | 1 | 2012 | 3031 | 0.050 |
Why?
|
| Genetic Variation | 1 | 2005 | 383 | 0.050 |
Why?
|
| Phylogeny | 1 | 2003 | 377 | 0.050 |
Why?
|
| Quetiapine Fumarate | 1 | 2021 | 13 | 0.050 |
Why?
|
| Gene Expression Regulation | 1 | 2008 | 1617 | 0.040 |
Why?
|
| Female | 6 | 2020 | 32991 | 0.040 |
Why?
|
| Male | 5 | 2020 | 29980 | 0.040 |
Why?
|
| Central Venous Pressure | 1 | 2020 | 14 | 0.040 |
Why?
|
| Child, Preschool | 2 | 2019 | 1998 | 0.040 |
Why?
|
| Computational Biology | 2 | 2018 | 355 | 0.040 |
Why?
|
| Aged, 80 and over | 2 | 2020 | 5493 | 0.040 |
Why?
|
| Time Factors | 1 | 2008 | 3769 | 0.040 |
Why?
|
| Proprotein Convertase 5 | 1 | 2019 | 1 | 0.040 |
Why?
|
| Furin | 1 | 2019 | 11 | 0.040 |
Why?
|
| Receptor, Insulin | 1 | 2019 | 50 | 0.040 |
Why?
|
| Vero Cells | 1 | 2019 | 80 | 0.040 |
Why?
|
| Health Planning Technical Assistance | 1 | 2018 | 1 | 0.040 |
Why?
|
| DNA Mutational Analysis | 1 | 2019 | 197 | 0.040 |
Why?
|
| Age of Onset | 1 | 2019 | 174 | 0.040 |
Why?
|
| Psychosocial Support Systems | 1 | 2018 | 12 | 0.040 |
Why?
|
| Exodeoxyribonucleases | 1 | 2018 | 29 | 0.040 |
Why?
|
| Middle Aged | 3 | 2020 | 17694 | 0.040 |
Why?
|
| Isoenzymes | 1 | 2018 | 139 | 0.040 |
Why?
|
| Hydrolysis | 1 | 2018 | 144 | 0.040 |
Why?
|
| Drug Evaluation, Preclinical | 1 | 2018 | 98 | 0.040 |
Why?
|
| Blood Pressure | 1 | 2020 | 512 | 0.040 |
Why?
|
| Length of Stay | 1 | 2021 | 815 | 0.030 |
Why?
|
| Cluster Analysis | 1 | 2018 | 265 | 0.030 |
Why?
|
| CHO Cells | 2 | 2011 | 189 | 0.030 |
Why?
|
| Phosphoproteins | 1 | 2018 | 220 | 0.030 |
Why?
|
| Cricetinae | 2 | 2011 | 367 | 0.030 |
Why?
|
| Cell Cycle Checkpoints | 1 | 2016 | 47 | 0.030 |
Why?
|
| Sequence Analysis, DNA | 1 | 2018 | 415 | 0.030 |
Why?
|
| Drug Therapy, Computer-Assisted | 1 | 2016 | 11 | 0.030 |
Why?
|
| High-Throughput Screening Assays | 1 | 2016 | 78 | 0.030 |
Why?
|
| Adolescent | 2 | 2019 | 6255 | 0.030 |
Why?
|
| Molecular Structure | 1 | 2016 | 385 | 0.030 |
Why?
|
| Decision Support Systems, Clinical | 1 | 2016 | 72 | 0.030 |
Why?
|
| Boston | 1 | 2016 | 253 | 0.030 |
Why?
|
| Mental Health | 1 | 2018 | 371 | 0.030 |
Why?
|
| Adenosine Triphosphatases | 1 | 2017 | 255 | 0.030 |
Why?
|
| Infant, Newborn | 1 | 2019 | 1361 | 0.030 |
Why?
|
| Aged | 2 | 2020 | 14505 | 0.030 |
Why?
|
| Academic Medical Centers | 1 | 2016 | 316 | 0.030 |
Why?
|
| Quality Improvement | 1 | 2018 | 446 | 0.030 |
Why?
|
| Infant | 1 | 2019 | 1654 | 0.030 |
Why?
|
| Consanguinity | 1 | 2013 | 6 | 0.030 |
Why?
|
| Child | 2 | 2019 | 4533 | 0.030 |
Why?
|
| Light | 2 | 2005 | 203 | 0.030 |
Why?
|
| Transferrin | 1 | 2013 | 70 | 0.020 |
Why?
|
| Cathepsin D | 1 | 2012 | 11 | 0.020 |
Why?
|
| Cell Proliferation | 1 | 2016 | 985 | 0.020 |
Why?
|
| Vacuolar Proton-Translocating ATPases | 1 | 2012 | 12 | 0.020 |
Why?
|
| Basic Helix-Loop-Helix Leucine Zipper Transcription Factors | 1 | 2012 | 39 | 0.020 |
Why?
|
| DNA Primers | 1 | 2012 | 292 | 0.020 |
Why?
|
| Blastocyst | 1 | 2012 | 72 | 0.020 |
Why?
|
| Long QT Syndrome | 1 | 2011 | 32 | 0.020 |
Why?
|
| Cricetulus | 1 | 2011 | 99 | 0.020 |
Why?
|
| Blotting, Western | 1 | 2012 | 612 | 0.020 |
Why?
|
| Polymerase Chain Reaction | 1 | 2012 | 517 | 0.020 |
Why?
|
| Hydrogen-Ion Concentration | 1 | 2012 | 458 | 0.020 |
Why?
|
| Algorithms | 1 | 2016 | 1005 | 0.020 |
Why?
|
| Retrospective Studies | 1 | 2021 | 6688 | 0.020 |
Why?
|
| RNA | 1 | 2012 | 423 | 0.020 |
Why?
|
| Hospitalization | 1 | 2016 | 1362 | 0.020 |
Why?
|
| alpha-Mannosidase | 1 | 2008 | 5 | 0.020 |
Why?
|
| Concanavalin A | 1 | 2008 | 40 | 0.020 |
Why?
|
| Mannosidases | 1 | 2007 | 2 | 0.020 |
Why?
|
| Trichomonas | 1 | 2007 | 2 | 0.020 |
Why?
|
| Carbohydrate Sequence | 1 | 2007 | 22 | 0.020 |
Why?
|
| Models, Chemical | 1 | 2008 | 139 | 0.020 |
Why?
|
| Mice, Knockout | 1 | 2012 | 2110 | 0.020 |
Why?
|
| Proteasome Endopeptidase Complex | 1 | 2007 | 126 | 0.020 |
Why?
|
| Mass Spectrometry | 1 | 2008 | 301 | 0.020 |
Why?
|
| Neurons | 1 | 2012 | 923 | 0.020 |
Why?
|
| Image Processing, Computer-Assisted | 1 | 2009 | 659 | 0.020 |
Why?
|
| Prolactin | 1 | 2005 | 40 | 0.010 |
Why?
|
| Glycopeptides | 1 | 2005 | 12 | 0.010 |
Why?
|
| Cross-Linking Reagents | 1 | 2005 | 117 | 0.010 |
Why?
|
| Cattle | 1 | 2005 | 311 | 0.010 |
Why?
|
| Plasmodium falciparum | 1 | 2007 | 246 | 0.010 |
Why?
|
| Predictive Value of Tests | 1 | 2007 | 1096 | 0.010 |
Why?
|
| Species Specificity | 1 | 2005 | 334 | 0.010 |
Why?
|
| Helminth Proteins | 1 | 2003 | 46 | 0.010 |
Why?
|
| Molecular Weight | 1 | 2003 | 187 | 0.010 |
Why?
|
| Alleles | 1 | 2003 | 447 | 0.010 |
Why?
|
| Bacteria | 1 | 2005 | 306 | 0.010 |
Why?
|
| Fibroblasts | 1 | 2003 | 394 | 0.010 |
Why?
|